CIK: 0001274403 · Show all filings
Period: Q2 2019 (← Previous) (Next →)
Filing Date: Aug 9, 2019
Total Value ($000): $96,589 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | RUBIUS THERAPEUTICS INC | 2,618,351 | $41,187 | 42.6% | $16.08 | — | COM | 78116T103 |
| KURA | KURA ONCOLOGY INC | 1,356,307 | $26,706 | 27.6% | $13.25 | +25.3% | COM | 50127T109 |
| FATE | FATE THERAPEUTICS INC | 973,190 | $19,756 | 20.5% | $13.94 | +29.2% | COM | 31189P102 |
| — | CHIASMA INC | 1,196,776 | $8,940 | 9.3% | $3.11 | — | COM | 16706W102 |